BCI Pharma is a company existing for 5 years in Montpellier, France. It has been relocated partly to Liège following a 3MM capital increase led by TheClubDeal. It has developed proofs of concepts in Biotech research on neuropathic pains, on a medical development articulated on kinase inhibitors, highly potent and targeted molecules.The business model consist in creating partnerships with larger players at early stage so to jointly develop applications and related cures and drug development.
We seek to customise the content to the segments we serve.
These are both fund investors and the entrepreneurs with whom we have created alliances.
We are happy to keep in touch.